Tag «KRAZATI»

Adagrasib

It’s only fair to share… Adagrasib Formula C32H35ClFN7O2 cas  2326521-71-3 Mol weight 604.1174 Antineoplastic   Disease Non-small cell lung cancer 2022/12/12 FDA APPROVED, KRAZATI (Mirati Therapeutics) MRTX-849 MRTX849 KRAS G12C inhibitor MRTX849 Adagrasib, sold under the brand name Krazati, is an anticancer medication used to treat non-small cell lung cancer.[1][2] Adagrasib is an inhibitor of the RAS GTPase family.[1] It is taken by mouth.[1] It …